I Boland
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
-
- Cancer therapeutics and mechanisms 8
- Oncology 7
- Lung Cancer Research Studies 5
- Co-authors
- Gilles Vassal (11 shared papers)Alain Gouyette (10 shared papers)Jackie Morizet (7 shared papers)Dominique Challine (4 shared papers)Olivier Hartmann (4 shared papers)Alain Deroussent (4 shared papers)Dominique Valteau‐Couanet (3 shared papers)Serge Koscielny (2 shared papers)
In The Last Decade
I Boland
14 papers receiving 524 citations
Peers
Comparison fields: 5 of 77
- Hematology 153
- Neurology 146
- Genetics 83
- Transplantation 19
- Pediatrics, Perinatology and Child Health 102
Countries citing papers authored by I Boland
This map shows the geographic impact of I Boland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Boland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Boland more than expected).
Fields of papers citing papers by I Boland
This network shows the impact of papers produced by I Boland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Boland. The network helps show where I Boland may publish in the future.
Co-authors
The 25 scholars most cited alongside I Boland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 89 | |
| 2 | 1995 | 83 | |
| 3 | 1993 | 74 | |
| 4 | 2008 | 47 | |
| 5 | 1997 | 45 | |
| 6 | Chronopharmacology of high-dose busulfan in children. | 1993 | 45 |
| 7 | 1997 | 40 | |
| 8 | 2003 | 38 | |
| 9 | 1998 | 31 | |
| 10 | Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity. | 1998 | 19 |
| 11 | 1999 | 12 | |
| 12 | 2006 | 8 | |
| 13 | Busulfan metabolism in cytosolic and microsomal mouse liver preparations | 1993 | 1 |
| 14 | 1997 | 1 | |
| 15 | 1993 | 0 |
About I Boland
I Boland is a scholar working on Molecular Biology, Oncology, Neurology, Public Health, Environmental and Occupational Health and Hematology, having authored 15 papers that have together received 533 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (8 papers), Lung Cancer Research Studies (5 papers), Neuroblastoma Research and Treatments (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Glioma Diagnosis and Treatment (3 papers), Acute Myeloid Leukemia Research (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Hematology (153 citations), Neurology (146 citations), Genetics (83 citations), Transplantation (19 citations) and Pediatrics, Perinatology and Child Health (102 citations). I Boland has collaborated with scholars based in France and Canada. Frequent co-authors include Gilles Vassal, Alain Gouyette, Jackie Morizet, Dominique Challine, Olivier Hartmann, Alain Deroussent, Dominique Valteau‐Couanet, Serge Koscielny, P Ardouin and Jean Bénard. Their work appears in journals such as British Journal of Cancer, International Journal of Cancer, Blood, Biochimie and Health Expectations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.